NovaBridge Biosciences (NBP) Equity Income (2020 - 2024)

NovaBridge Biosciences (NBP) has 3 years of Equity Income data on file, last reported at $2.1 million in Q4 2024.

• Quarterly Equity Income rose 371.73% year-over-year to $2.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.0 million (down 79.14% YoY) and the FY2025 annual result came in at $5.2 million, up 397.5% from the prior year.
• Equity Income rose to $2.1 million in Q4 2024 per NBP's latest filing, from -$1.0 million in the prior quarter.
• Across five years, Equity Income topped out at $10.2 million in Q4 2020 and bottomed at -$2.4 million in Q3 2023.
• The 3-year median for Equity Income is -$901000.0 (2023), against an average of $1.0 million.
• Peak annual rise in Equity Income reached 371.73% in 2024, while the deepest fall reached 371.73% in 2024.
• Tracing NBP's Equity Income over 3 years: stood at $10.2 million in 2020, then plunged by 107.51% to -$764000.0 in 2023, then surged by 371.73% to $2.1 million in 2024.
• Per Business Quant, the three latest NBP Equity Income figures stand at $2.1 million (Q4 2024), -$1.0 million (Q1 2024), and -$764000.0 (Q4 2023).

Peer Comparison